UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$278M |
| 2 |
United Rentals
URI
|
+$213M |
| 3 |
Affiliated Managers Group
AMG
|
+$189M |
| 4 |
Yelp
YELP
|
+$146M |
| 5 |
Microsoft
MSFT
|
+$145M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$223M |
| 2 |
RTX Corp
RTX
|
+$188M |
| 3 |
AGN
Allergan Inc
AGN
|
+$184M |
| 4 |
Crown Castle
CCI
|
+$171M |
| 5 |
Mastercard
MA
|
+$128M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.34% |
| 2 | Technology | 14.73% |
| 3 | Financials | 14.56% |
| 4 | Consumer Discretionary | 9.63% |
| 5 | Industrials | 8.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1676
Sinclair Inc
SBGI
$1.07B
| $741K | ﹤0.01% |
27,098
+1,400
| +5% | +$38.1K |
|
1677
Equinor
EQNR
$93.7B
| $739K | ﹤0.01% |
41,959
-4,366
| -9% | -$93.1K |
|
|
MGLN
1678
DELISTED
Magellan Health Services, Inc.
MGLN
| $738K | ﹤0.01% |
12,299
+600
| +5% | +$35.4K |
|
1679
AB InBev
BUD
$165B
| $733K | ﹤0.01% |
6,523
+65
| +1% | +$7.2K |
|
|
HRG
1680
DELISTED
HRG Group, Inc.
HRG
| $733K | ﹤0.01% |
51,800
+15,800
| +44% | +$209K |
|
1681
MGE Energy Inc
MGEE
$3.05B
| $732K | ﹤0.01% |
16,050
| – | – |
|
1682
KB Home
KBH
$3.49B
| $731K | ﹤0.01% |
44,198
+1,900
| +4% | +$30.5K |
|
|
ABCO
1683
DELISTED
Advisory Board Co
ABCO
| $731K | ﹤0.01% |
14,921
+700
| +5% | +$33K |
|
1684
Pricesmart
PSMT
$5.5B
| $730K | ﹤0.01% |
8,000
+1,800
| +29% | +$163K |
|
1685
Ligand Pharmaceuticals
LGND
$6.02B
| $729K | ﹤0.01% |
21,979
+1,166
| +6% | +$37.9K |
|
|
BGC
1686
DELISTED
General Cable Corporation
BGC
| $729K | ﹤0.01% |
48,929
-18,600
| -28% | -$260K |
|
|
EDE
1687
DELISTED
Empire District Electric
EDE
| $728K | ﹤0.01% |
24,498
+7,200
| +42% | +$199K |
|
1688
Healthcare Services Group
HCSG
$1.51B
| $727K | ﹤0.01% |
23,498
+1,400
| +6% | +$41.5K |
|
1689
New York Times
NYT
$10.4B
| $727K | ﹤0.01% |
54,995
+3,300
| +6% | +$42.5K |
|
|
MTGE
1690
DELISTED
MTGE Investment Corp. Common Stock
MTGE
| $727K | ﹤0.01% |
38,598
+1,800
| +5% | +$35.3K |
|
|
PMCS
1691
DELISTED
P M C SIERRA INC
PMCS
| $726K | ﹤0.01% |
79,294
| – | – |
|
1692
First Citizens BancShares
FCNCA
$25.5B
| $723K | ﹤0.01% |
2,860
+800
| +39% | +$194K |
|
1693
G. Willi-Food International
WILC
$392M
| $723K | ﹤0.01% |
104,316
-178
| -0.2% | -$1.21K |
|
|
SWC
1694
DELISTED
Stillwater Mining Co
SWC
| $722K | ﹤0.01% |
48,997
+2,900
| +6% | +$39.8K |
|
|
BCPC
1695
Balchem Corp
BCPC
$5.75B
| $720K | ﹤0.01% |
10,799
+600
| +6% | +$37.4K |
|
|
MDP
1696
DELISTED
Meredith Corporation
MDP
| $717K | ﹤0.01% |
13,199
+700
| +6% | +$35.1K |
|
|
LL
1697
DELISTED
LL Flooring Holdings, Inc.
LL
| $712K | ﹤0.01% |
10,734
+800
| +8% | +$46.3K |
|
1698
Lazard
LAZ
$4.22B
| $710K | ﹤0.01% |
14,200
| – | – |
|
1699
Monro
MNRO
$388M
| $709K | ﹤0.01% |
12,268
| – | – |
|
1700
B&G Foods
BGS
$278M
| $706K | ﹤0.01% |
23,598
+6,000
| +34% | +$174K |
|
Similar funds
UBS AM's Q4 2014 Portfolio in Review
As of Q4 2014, UBS AM held 2,689 positions worth $105B, up 4.2% from $101B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
UBS AM's Q4 2014 filing shows 129 new, 1,370 increased, 628 reduced and 77 closed positions. Its largest new stake was Restaurant Brands International: 383,271 shares worth $15.1M. The largest sale was Biogen, an estimated $223M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 15% a quarter earlier, followed by Technology and Financials.
- UBS AM's largest Q4 2014 buy was Restaurant Brands International: 383,271 shares worth $15.1M.
- UBS AM added most to Celgene Corp in Q4 2014, an estimated $278M increase.
- UBS AM's biggest Q4 2014 reduction was Biogen, cutting an estimated $223M.
- UBS AM fully exited KINDER MORGAN MANAGEMENT LLC in Q4 2014, selling an estimated $45.3M.
- UBS AM's ten largest holdings make up 14% of its $105B portfolio in Q4 2014.
- UBS AM opened 129 new positions and closed 77 in Q4 2014.
- UBS AM's portfolio value rose 4.2% quarter-over-quarter to $105B.
Based on UBS AM's 13F filing for Q4 2014, filed 2 Feb 2015.